What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
Henrik Zetterberg mainly investigates Pathology, Cerebrospinal fluid, Alzheimer's disease, Internal medicine and Dementia.
His work carried out in the field of Pathology brings together such families of science as Biomarker and Multiple sclerosis.
His Cerebrospinal fluid study combines topics in areas such as Tau protein, Csf biomarkers, Immunology and Amyloid.
In his research on the topic of Alzheimer's disease, Drug development is strongly related with Bioinformatics.
His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Oncology.
Disease covers Henrik Zetterberg research in Dementia.
His most cited work include:
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study (1386 citations)
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. (1262 citations)
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cerebrospinal fluid, Internal medicine, Disease, Pathology and Biomarker.
In Cerebrospinal fluid, Henrik Zetterberg works on issues like Amyloid, which are connected to Amyloid precursor protein.
His Dementia and Alzheimer's disease investigations are all subjects of Internal medicine research.
Henrik Zetterberg combines subjects such as Apolipoprotein E and Cohort with his study of Dementia.
The concepts of his Disease study are interwoven with issues in Neuroimaging, Neuroscience and Clinical trial, Bioinformatics.
His work on Multiple sclerosis expands to the thematically related Pathology.
He most often published in these fields:
- Cerebrospinal fluid (61.53%)
- Internal medicine (52.68%)
- Disease (43.24%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (52.68%)
- Disease (43.24%)
- Cerebrospinal fluid (61.53%)
In recent papers he was focusing on the following fields of study:
Henrik Zetterberg spends much of his time researching Internal medicine, Disease, Cerebrospinal fluid, Biomarker and Dementia.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology, Neurology and Oncology.
His Disease research is multidisciplinary, incorporating perspectives in Clinical trial and Neuroscience.
His study on Cerebrospinal fluid is covered under Pathology.
Henrik Zetterberg has included themes like Prospective cohort study, Glial fibrillary acidic protein, Cohort and Atrophy in his Biomarker study.
His research in Dementia intersects with topics in Alzheimer's disease and Apolipoprotein E.
Between 2019 and 2021, his most popular works were:
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (135 citations)
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. (123 citations)
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. (115 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
The scientist’s investigation covers issues in Internal medicine, Disease, Biomarker, Cerebrospinal fluid and Dementia.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology, Neurology and Oncology.
His research investigates the connection between Disease and topics such as Differential diagnosis that intersect with issues in Retrospective cohort study.
His Biomarker research is multidisciplinary, incorporating elements of Atrophy, PRNP, Neuropathology, Prospective cohort study and Cohort.
His Cerebrospinal fluid research entails a greater understanding of Pathology.
His study in Dementia is interdisciplinary in nature, drawing from both Alzheimer's disease, Apolipoprotein E, Amyloid beta and Amyloid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
